|
|
Volumn 16, Issue 12, 2001, Pages 2439-2440
|
|
Is the use of subcutaneous epoetin β once a week really equivalent to a more frequent administration of the same total dose?
a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEMOGLOBIN;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
BIOEQUIVALENCE;
CALCULATION;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FOLLOW UP;
HEMODIALYSIS PATIENT;
HUMAN;
LETTER;
METHODOLOGY;
PREDICTION;
PRIORITY JOURNAL;
SAMPLE;
STATISTICAL ANALYSIS;
ANEMIA;
DRUG ADMINISTRATION SCHEDULE;
ERYTHROPOIETIN;
ERYTHROPOIETIN, RECOMBINANT;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
RENAL DIALYSIS;
|
|
EID: 0035207269
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/16.12.2439 Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|